In order to meet the regulatory requirements (Novel Food application) and to open up the outstanding prospects of the CBD market (food and nutritional supplements) for our members and partners, EIHA is conducting a Novel Food application for CBD isolates and hemp extracts. The subsidiary responsible for this, EIHA projects GmbH, is investing a total of approx. 3.5 million EUR in the necessary toxicology studies on CBD and THC. The complete submission of all study data is expected in mid-2024.
Language: German
Speaker
- Daniel Kruse (Speaker), EIHA, President